RA Capital Management, LLC, 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), bought 2,369,229 shares at $2.76 ($6.6M) on 2013-10-14, disclosed to the SEC on 2013-10-16.
Open-market purchase of $6.6M ACHN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.76 | 81,200 | $224K | 3.4% |
| 2 | $2.77 | 13,200 | $37K | 0.6% |
| 3 | $2.77 | 475,699 | $1.3M | 19.9% |
| 4 | $2.78 | 230,100 | $640K | 9.7% |
| 5 | $2.79 | 950,000 | $2.7M | 40.0% |
| 6 | $2.80 | 206,000 |
| $577K |
| 8.7% |
| 7 | $2.84 | 369,900 | $1.1M | 15.9% |
| 8 | $2.85 | 43,130 | $123K | 1.9% |
| Total | $2.79 avg | 2,369,229 | $6.6M | 100% |
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |